PubMed

Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy.

Ballatori E, Roila F.

Health Qual Life Outcomes. 2003 Sep 17;1:46. Review.PMID: 14521717 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone.

Lindley C, Goodin S, McCune J, Kane M, Amamoo MA, Shord S, Pham T, Yowell S, Laliberte K, Schell M, Bernard S, Socinski MA.

Am J Clin Oncol. 2005 Jun;28(3):270-6.PMID: 15923800 [PubMed - indexed for MEDLINE]Related articles

[Recent improvements in antiemetic therapy]

Roila F, Palladino MA, Ciccarese G, Basurto C.

Tumori. 1997;83(2 Suppl):S3-14. Review. Italian. PMID: 9235727 [PubMed - indexed for MEDLINE]Related articles

[Research on antiemetics: an Italian model of success]

Roila F.

Tumori. 1998 Jan-Feb;84(1 Suppl):S3-11. Review. Italian. PMID: 9617377 [PubMed - indexed for MEDLINE]Related articles

Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting.

Tan L, Liu J, Liu X, Chen J, Yan Z, Yang H, Zhang D.

J Exp Clin Cancer Res. 2009 Sep 23;28:131.PMID: 19775450 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.

Yeo W, Mo FK, Suen JJ, Ho WM, Chan SL, Lau W, Koh J, Yeung WK, Kwan WH, Lee KK, Mok TS, Poon AN, Lam KC, Hui EK, Zee B.

Breast Cancer Res Treat. 2009 Feb;113(3):529-35. Epub 2008 Mar 10.PMID: 18327706 [PubMed - indexed for MEDLINE]Related articles

Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.

[No authors listed]

J Clin Oncol. 1997 Jan;15(1):124-30.PMID: 8996133 [PubMed - indexed for MEDLINE]Related articles

Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting.

Dando TM, Perry CM.

Drugs. 2004;64(7):777-94. Review.PMID: 15025555 [PubMed - indexed for MEDLINE]Related articles

Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy. The Italian Group for Antiemetic Research.

[No authors listed]

N Engl J Med. 2000 May 25;342(21):1554-9.PMID: 10824073 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.

Bruntsch U, Drechsler S, Eggert J, Gosse H, Ukena D, Imhoff W, Faerber L.

Semin Oncol. 1994 Oct;21(5 Suppl 9):7-11.PMID: 9113120 [PubMed - indexed for MEDLINE]Related articles

New antiemetic drugs.

Roila F, Fatigoni S.

Ann Oncol. 2006 Mar;17 Suppl 2:ii96-100. Review.PMID: 16608997 [PubMed - indexed for MEDLINE]Related articlesFree article

Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting.

Simpson K, Spencer CM, McClellan KJ.

Drugs. 2000 Jun;59(6):1297-315. Review.PMID: 10882164 [PubMed - indexed for MEDLINE]Related articles

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.

Saito M, Aogi K, Sekine I, Yoshizawa H, Yanagita Y, Sakai H, Inoue K, Kitagawa C, Ogura T, Mitsuhashi S.

Lancet Oncol. 2009 Feb;10(2):115-24. Epub 2009 Jan 8.PMID: 19135415 [PubMed - indexed for MEDLINE]Related articles

Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.

Chiou TJ, Tzeng WF, Wang WS, Yen CC, Fan FS, Liu JH, Chen PM.

Zhonghua Yi Xue Za Zhi (Taipei). 2000 Oct;63(10):729-36.PMID: 11076429 [PubMed - indexed for MEDLINE]Related articles

Omission of day 2 of antiemetic medications is a cost saving strategy for improving chemotherapy-induced nausea and vomiting control: results of a randomized phase III trial.

Lajolo PP, de Camargo B, del Giglio A.

Am J Clin Oncol. 2009 Feb;32(1):23-6.PMID: 19194119 [PubMed - indexed for MEDLINE]Related articles

Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy.

Plosker GL, Milne RJ.

Pharmacoeconomics. 1992 Oct;2(4):285-304. Review.PMID: 10147044 [PubMed - indexed for MEDLINE]Related articles

Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy.

Grunberg SM, Dugan M, Muss H, Wood M, Burdette-Radoux S, Weisberg T, Siebel M.

Support Care Cancer. 2009 May;17(5):589-94. Epub 2008 Nov 27.PMID: 19037667 [PubMed - indexed for MEDLINE]Related articles

Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.

Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J.

J Clin Oncol. 2006 Sep 20;24(27):4472-8.PMID: 16983116 [PubMed - indexed for MEDLINE]Related articles

A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.

Sorbe BG, Högberg T, Glimelius B, Schmidt M, Wernstedt L, Hansen O, Sörensen BT, Räisänen I, van Oosterom AT, de Bruijn KM.

Cancer. 1994 Jan 15;73(2):445-54.PMID: 8293412 [PubMed - indexed for MEDLINE]Related articles

Antiemetics revisited.

Roila F, Del Favero A.

Curr Opin Oncol. 1997 Jul;9(4):321-6. Review.PMID: 9251881 [PubMed - indexed for MEDLINE]Related articles